Texas Vaccine Outreach and Education Grant
Inform, connect and protect your community.
The Texas Vaccine Outreach and Education Grant program is a partnership between Texas A&M Health and the Texas Department of State Health Services Immunization Unit to fund strategies that ensure greater knowledge of and access to COVID-19 vaccines by those disproportionately affected by COVID-19.
Community-based organizations (CBOs) will be awarded funds to engage their community in proactive COVID-19 vaccine education and outreach activities with the goal of increasing the number of people fully vaccinated for COVID-19 in Texas.
Preventing disparities in the uptake of COVID-19 vaccines is important to mitigate the disproportionate impacts of the virus. Reaching high vaccination rates across individuals and communities will be key for achieving broader population immunity through a vaccine. Lower vaccination rates among some groups will leave them at increased risk for infection, particularly as new variants spread.
For more information email us at vaccinegrant@tamu.edu.
To view the funded organizations for Round 1 and read the press release from Texas A&M Health and the Texas Department of State Health Services click HERE.
FREQUENTLY ASKED QUESTIONS
Based on current knowledge, experts believe that COVID-19 vaccines are unlikely to pose a risk to a person trying to become pregnant in the short or long term. Scientists study every vaccine carefully for side effects immediately and for years afterward, and people who get vaccinated track their symptoms. The COVID-19 vaccines are being studied carefully now, and the side effects data will continue to be studied for many years, similar to other vaccines.
There is currently no evidence that antibodies formed from COVID-19 vaccination cause any problems with pregnancy. In addition, there is no evidence suggesting that fertility problems are a side effect of ANY vaccine. People who are trying to become pregnant now or who plan to try in the future may receive the COVID-19 vaccine when it becomes available to them.
Relevant statistics
Moderna: 10 cases of allergic reaction with 4 million doses delivered (0.0003%). In 9 of those 10 cases, the reaction occurred within 15 minutes.